COLORADO SPRINGS, Colo., Oct. 31 /PRNewswire-FirstCall/ -- Spectranetics Corporation today announced that it will present at the Rodman and Renshaw 8th Annual Healthcare Conference to be held on November 6-8 at the Palace Hotel in New York.
John G. Schulte, Spectranetics’ president and chief executive officer, is scheduled to speak on Tuesday, November 7, at 10:15 a.m. Eastern time (7:15 a.m. Pacific time) and will discuss the Company’s strategic initiatives, product pipeline and market opportunities.
Interested parties can access a live audio webcast and slide presentation at www.spectranetics.com. An archived presentation will be available on the Web site for 14 days.
About Spectranetics
Spectranetics is a medical device company that develops, manufactures and markets single-use medical devices used in minimally invasive surgical procedures within the cardiovascular system in conjunction with its proprietary excimer laser system. Its CVX-300(R) excimer laser is the only system approved by the FDA for multiple cardiovascular procedures, including coronary atherectomy, and the removal of problematic pacemaker and defibrillator leads. Nearly all of the company’s FDA-approved and investigational applications have received Communautes Europeennes (CE) mark registration for marketing within Europe. In April 2004 Spectranetics obtained 510(k) clearance from the FDA for the laser-based treatment of patients suffering from total occlusions (blockages) in their leg arteries that are not crossable with a guide wire.
COMPANY CONTACT: INVESTOR & MEDIA CONTACTS: Spectranetics Corporation Lippert/Heilshorn & Associates, Inc. Guy Childs, Chief Financial Officer Bruce Voss or Don Markley (719) 633-8333 (310) 691-7100 www.spectranetics.comwww.lhai.com
Spectranetics Corporation
CONTACT: Guy Childs, Chief Financial Officer of Spectranetics Corporation,+1-719-633-8333; or Bruce Voss or Don Markley, both of Lippert/Heilshorn &Associates, Inc., +1-310-691-7100, for Spectranetics Corporation
Web site: http://www.spectranetics.com/
